|
GlaxoSmithKline Consumer Healthcare Sales up 20% for the quarter ended September 30, 2008
Sales up 20% and Profits up 5%
Highlights for the quarter______________________________________________________
Sustained robust sales growth
Interim dividend declared at the rate of 100%.
Initiatives taken to control cost to offset impact of rising commodity prices
Overview________________________________________________________________________________
GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the quarter ended September 30, 2008. For the third quarter revenues were up by 20% at Rs. 4,22,48 lacs, PBT & PAT by 2% at Rs. 77,75 lacs and 5 % at Rs. 53,03 lacs respectively.
The Board of Directors also declared an interim dividend of Rs. 10 per equity share.
Sales of all brands continued to grow during the third quarter as well. In order to offset the impact of rise of commodity prices, the company has taken several initiatives to control costs of its products. Heavy investments behind brands, focus on innovations and investments in media are driving brand equity and franchise.
"We continue to build robust pipeline of products and innovations and maintain focus on controlling cost, invest behind our brands and on new product developments." said Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Ltd.
___________________________________________________________________________________________________________________________
About GlaxoSmithKline Consumer Healthcare
Ltd.
GSKCH is an
associate of GlaxoSmithKline plc. of the U.K, a
global science based healthcare company. GSKCH
has continually benefited from the technical and
marketing inputs that have been available as a
consequence of this association. GSKCH is the
largest player in the health food drinks
industry. The Company with its manufacturing
plants located in Nabha,
Rajahmundry
and Sonepat
has a total workforce of about 2700 people.
GSKCH has a
strong marketing and distribution network in
India comprising over 1800 wholesalers and
direct coverage of over 4,50,000 retail outlets.
Its flagship product, Horlicks, is a widely
regarded and highly respected brand for over 100
years. The Company also manufactures and markets
Boost, Viva and Maltova and in addition markets
and distributes a number of products in diverse
categories, which include prominent household
names such as Eno, Crocin and Iodex.
Media Contacts ______________________________________________________
Debosmita Majumder / Shrey Khetarpal
Genesis Burson-Marsteller
Tel: 91-124-4044999 (Extn. 172 / 157); Fax: 91-124-4044744
Hand-phone: +91 98733-82955 / +91 98115-25715
Email: debosmita.majumder@bm.com / shrey.khetarpal@bm.com
|
